Ostatní
Návod 
Omnicell, Inc.
OMCL
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.7B
Obrat
1B
Zisk
0B
Aktiva
2B
Dluh
0B
ROE
0%
ROA
0%
PE
793
PS
1
Cena 1R
23-55
⌀ Cena
33.35
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
05-02-2026
Poslední dividenda
Profil
Společnost Omnicell, Inc. spolu se svými dceřinými společnostmi poskytuje řešení pro řízení léků a přilnavé nástroje pro zdravotnické systémy a lékárny ve Spojených státech a na mezinárodní úrovni. Společnost nabízí automatizační řešení pro místa péče s cílem zlepšit pracovní postupy klinických lékařů v oblastech péče o pacienty ve zdravotnickém systému; automatické dávkovací systémy XT Series pro léky a potřeby používané v ošetřovatelských zařízeních a dalších klinických oblastech nemocnice, jakož i specializované automatické dávkovací systémy pro operační sál; software Omnicell Interface Software, který nabízí rozhraní a integraci mezi svými produkty pro použití léků nebo zásobovacími produkty, a interní informační systémy zdravotnického zařízení; a robotické dávkovací systémy pro manipulaci se skladováním a vyhledáváním boxovaných léků. Poskytuje také automatizační řešení centrálních lékáren, včetně automatizovaných skladovacích a vyhledávacích systémů, jako je XR2 Automated Central Pharmacy System, IV komponujících robotů a systémů řízení pracovních postupů, software pro řízení zásob a systémy řízení kontrolovaných látek. Kromě toho společnost nabízí automatizační řešení s jednou dávkou, která vyplňují a označují různé blistrové obaly pro pacienty, jednodávkové léky na základě vstupních předpisů; plně automatizované a poloautomatické plnicí zařízení pro institucionální lékárny, které zaručuje automatické balení léků; a obaly s blistrovými kartami pro léky a obaly pro zlepšení dodržování léků v prostředí neakutní péče. Dále nabízí EnlivenHealth Patient Engagement, internetové spojení řešení. Společnost byla dříve známá jako Omnicell Technologies, Inc. a v roce 2001 změnila své jméno na Omnicell, Inc. Společnost Omnicell, Inc. byla založena v roce 1992 a sídlí v Mountain View v Kalifornii.
Sektor
Healthcare
Odvětví
Medical - Healthcare Information Services
Počet zaměstnanců
3620
Založení
2001-08-09
Podobné společnosti
$ 23.83
+ $ 1.46
$ 18.29
+ $ 0.51
$ 7.55
+ $ 0.02
$ 16.56
+ $ 1.31
$ 22.33
+ $ 0.31
$ 231.91
+ $ 5.80
$ 3.04
- $ 0.08
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 1,184.8 | 1,184.8 | 1,112.2 | 1,147.1 | 1,295.9 | 1,132.0 | 892.2 | 897.0 | 787.3 | 716.2 | 692.6 | 484.6 | 440.9 | 380.6 | 314.0 | 245.5 | 222.4 | |
| Cost of Revenues | 681.4 | 681.4 | 641.2 | 647.2 | 707.0 | 577.4 | 478.9 | 460.1 | 415.0 | 394.1 | 378.8 | 236.6 | 207.0 | 177.2 | 143.5 | 109.8 | 104.5 | |
| Gross Profit | 503.4 | 503.4 | 471.0 | 499.9 | 589.0 | 554.7 | 413.3 | 436.9 | 372.3 | 322.1 | 313.8 | 247.9 | 233.9 | 203.4 | 170.6 | 135.8 | 117.9 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 314.0 | 310.6 | 290.6 | 269.7 | 306.9 | 282.4 | 276.8 | 246.2 | 258.8 | 298.7 | |
| Cost of Revenues | 183.7 | 176.1 | 162.9 | 158.7 | 164.0 | 159.5 | 162.4 | 150.8 | 153.4 | 166.7 | |
| Gross Profit | 130.3 | 134.5 | 127.7 | 110.9 | 142.9 | 122.9 | 114.4 | 95.3 | 105.4 | 132.0 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 97.1 | 105.0 | 75.7 | 70.2 | 68.6 | 64.8 | 66.0 | 57.8 | 35.2 | 27.8 | 29.1 | 23.7 | 22.0 | 21.0 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 434.6 | 486.3 | 389.4 | 307.6 | 289.9 | 263.1 | 250.3 | 249.5 | 167.6 | 156.5 | 139.0 | 119.7 | 97.5 | 86.2 | |
| Depreciation & Amortization | 80.6 | 78.8 | 89.8 | 95.6 | 99.2 | 84.9 | 71.6 | 64.1 | 51.4 | 51.5 | 58.4 | 25.6 | 20.3 | 18.4 | 13.3 | 8.0 | 8.6 | |
| Total Operating Expenses | 498.3 | 498.3 | 470.7 | 534.8 | 591.3 | 465.1 | 377.8 | 358.6 | 327.9 | 316.3 | 307.3 | 202.7 | 184.3 | 168.1 | 143.5 | 119.6 | 107.2 | |
| Operating Income | 5.2 | 5.2 | 0.3 | -34.9 | -2.3 | 89.5 | 35.5 | 78.4 | 44.4 | 5.8 | 6.5 | 48.6 | 49.6 | 35.3 | 27.1 | 16.2 | 9.5 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 26.8 | 24.3 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 102.0 | 104.0 | ||
| Depreciation & Amortization | 19.8 | 19.4 | 19.6 | 21.8 | 22.2 | 21.6 | 22.8 | 23.2 | 95.6 | 23.6 | ||
| Total Operating Expenses | 129.9 | 126.3 | 119.6 | 122.6 | 129.2 | 115.7 | 111.1 | 114.0 | 128.8 | 128.3 | ||
| Operating Income | 0.4 | 8.2 | 8.1 | -11.6 | 13.8 | 7.2 | 3.2 | -18.7 | -23.4 | 3.7 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 10.9 | 0.0 | 24.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.3 | 0.4 | |
| Interest Expense | 2.4 | 6.2 | 4.5 | 0.0 | 0.1 | -23.5 | -6.2 | -4.4 | -8.8 | -6.6 | -8.4 | -2.4 | -1.1 | 0.1 | 0.0 | 0.1 | 0.0 | |
| Other Expense | 6.2 | 6.2 | 25.3 | 14.8 | -0.1 | -23.5 | -6.2 | -4.4 | -8.8 | -6.6 | -8.4 | 3.4 | -1.1 | -0.2 | -0.1 | -0.1 | -0.7 | |
| IBT | 11.3 | 11.3 | 25.6 | -20.1 | -2.5 | 66.0 | 29.3 | 73.9 | 35.6 | -0.9 | -1.9 | 46.2 | 48.5 | 35.0 | 27.0 | 16.1 | 10.0 | |
| Income Tax Expense | 9.3 | 9.3 | 13.1 | 0.3 | -8.1 | -11.8 | -2.8 | 12.6 | -2.1 | -21.5 | -2.6 | 15.5 | 18.0 | 11.1 | 10.9 | 5.7 | 5.1 | |
| Net Income | 2.1 | 2.1 | 12.5 | -20.4 | 5.6 | 77.8 | 32.2 | 61.3 | 37.7 | 20.6 | 0.6 | 30.8 | 30.5 | 24.0 | 16.2 | 10.4 | 4.9 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 3.6 | 3.7 | 3.6 | 0.0 | 0.0 | 0.0 | 0.0 | 4.8 | 3.7 | ||
| Interest Expense | 0.3 | 1.5 | 0.3 | 0.3 | 1.1 | 1.1 | 1.1 | 1.1 | 4.8 | 3.7 | ||
| Other Expense | 0.3 | 1.5 | 2.3 | 2.1 | 9.8 | 4.4 | 5.0 | 0.9 | 4.8 | 3.7 | ||
| IBT | 0.7 | 9.7 | 10.5 | -9.5 | 23.6 | 11.6 | 8.2 | -17.8 | -18.5 | 7.4 | ||
| Income Tax Expense | 2.7 | 4.2 | 4.8 | -2.5 | 7.8 | 3.0 | 4.5 | -2.2 | -4.1 | 1.8 | ||
| Net Income | -2.0 | 5.5 | 5.6 | -7.0 | 15.8 | 8.6 | 3.7 | -15.7 | -14.4 | 5.6 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-0.45 | $0.13 | $1.79 | $0.76 | $1.48 | $0.96 | $0.81 | $0.27 | $0.86 | $0.86 | $0.69 | $0.49 | $0.31 | $0.15 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-0.45 | $0.12 | $1.62 | $0.74 | $1.43 | $0.93 | $0.79 | $0.26 | $0.84 | $0.83 | $0.67 | $0.47 | $0.30 | $0.15 | |
| Shares Outstanding | 45.0 | 46.0 | 46.0 | 45.2 | 44.4 | 43.5 | 42.6 | 41.5 | 39.2 | 37.5 | 36.2 | 35.9 | 35.7 | 34.7 | 33.3 | 33.1 | 32.7 | |
| Diluted Shares Outstanding | 45.0 | 46.4 | 46.3 | 45.2 | 45.9 | 47.9 | 43.7 | 42.9 | 40.6 | 38.7 | 36.9 | 36.7 | 36.6 | 35.8 | 34.2 | 34.1 | 33.5 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.32 | $0.12 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.32 | $0.12 | ||
| Shares Outstanding | 45.0 | 46.3 | 46.7 | 46.6 | 46.0 | 46.2 | 46.0 | 45.7 | 45.5 | 45.3 | ||
| Diluted Shares Outstanding | 45.0 | 46.7 | 46.7 | 46.6 | 46.3 | 46.4 | 46.0 | 45.7 | 45.5 | 45.6 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 578.3 | 369.2 | 468.0 | 330.4 | 349.1 | 485.9 | 127.2 | 67.2 | 32.4 | 54.5 | 82.2 | 125.9 | 104.5 | 62.3 | 191.8 | 175.6 | |
| Short Term Investments | 12.6 | 12.5 | 0.0 | 11.5 | 10.7 | 10.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.1 | 8.1 | |
| Total Cash & ST Investments | 578.3 | 381.7 | 468.0 | 330.4 | 349.1 | 485.9 | 127.2 | 67.2 | 32.4 | 54.5 | 82.2 | 125.9 | 104.5 | 62.3 | 199.9 | 183.7 | |
| Accounts Receivable | 253.7 | 256.4 | 263.9 | 299.5 | 240.9 | 190.1 | 218.4 | 196.2 | 189.2 | 150.3 | 108.0 | 82.8 | 58.6 | 55.1 | 36.9 | 42.7 | |
| Inventory | 93.3 | 88.7 | 110.1 | 147.5 | 119.9 | 96.3 | 108.0 | 100.9 | 96.1 | 69.3 | 46.6 | 31.6 | 31.5 | 26.9 | 18.1 | 9.8 | |
| Other Current Assets | 70.4 | 88.8 | 85.6 | 77.4 | 48.3 | 41.0 | 15.2 | 12.1 | 13.3 | 12.7 | 7.8 | 7.2 | 7.7 | 9.1 | 6.1 | 7.1 | |
| Total Current Assets | 995.7 | 815.5 | 927.6 | 881.8 | 780.7 | 829.4 | 483.2 | 397.1 | 367.1 | 315.4 | 264.1 | 283.4 | 233.8 | 180.9 | 279.4 | 268.5 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 180.1 | 399.0 | 386.8 | 369.2 | 570.6 | 556.8 | 512.4 | 501.0 | 446.8 | 399.5 | |
| Short Term Investments | 0.0 | 12.6 | 12.6 | 12.5 | 11.7 | 12.6 | 12.0 | 11.9 | 11.6 | 11.1 | |
| Total Cash & ST Investments | 180.1 | 411.6 | 399.4 | 381.7 | 582.3 | 569.4 | 524.4 | 501.0 | 446.8 | 399.5 | |
| Accounts Receivable | 245.7 | 232.7 | 251.6 | 256.4 | 251.8 | 241.1 | 248.5 | 263.9 | 272.6 | 273.9 | |
| Inventory | 107.4 | 105.8 | 91.1 | 88.7 | 95.1 | 93.3 | 103.5 | 110.1 | 116.1 | 130.6 | |
| Other Current Assets | 126.4 | 94.7 | 97.5 | 88.8 | 82.1 | 91.9 | 113.5 | 85.6 | 78.2 | 77.4 | |
| Total Current Assets | 659.6 | 844.8 | 839.7 | 815.5 | 1,011.3 | 995.7 | 989.9 | 927.6 | 913.8 | 881.4 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 137.4 | 138.3 | 133.6 | 132.0 | 119.7 | 114.2 | 110.4 | 51.5 | 42.6 | 42.0 | 32.3 | 36.2 | 35.3 | 34.3 | 17.3 | 14.4 | |
| Goodwill | 735.4 | 734.7 | 735.8 | 734.3 | 738.9 | 499.3 | 336.5 | 335.9 | 337.8 | 327.7 | 147.9 | 122.7 | 111.3 | 113.4 | 28.5 | 28.5 | |
| Intangible Assets | 260.3 | 246.7 | 277.8 | 242.9 | 277.6 | 168.2 | 124.9 | 143.7 | 168.1 | 190.3 | 89.7 | 82.7 | 81.6 | 85.2 | 4.2 | 4.7 | |
| Long-Term Investments | 60.2 | 52.7 | 54.8 | 32.9 | 18.4 | 22.2 | 19.8 | 17.1 | 15.4 | 20.6 | 14.5 | 10.8 | 11.5 | 13.2 | 8.8 | 9.2 | |
| Other Long-Term Assets | 62.2 | 75.5 | 64.4 | 164.5 | 191.3 | 176.2 | 151.9 | 120.8 | 39.8 | 35.1 | 27.9 | 23.3 | 17.9 | 15.8 | 9.7 | 8.4 | |
| Total Long-Term Assets | 1,296.0 | 1,305.5 | 1,299.3 | 1,328.9 | 1,361.8 | 995.1 | 757.6 | 684.1 | 613.2 | 619.7 | 314.6 | 276.8 | 258.7 | 262.8 | 82.6 | 74.8 | |
| Total Assets | 2,291.7 | 2,121.0 | 2,226.9 | 2,210.8 | 2,142.5 | 1,824.5 | 1,240.8 | 1,081.2 | 980.3 | 935.1 | 578.7 | 560.2 | 492.5 | 443.7 | 362.0 | 343.3 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 145.7 | 147.2 | 145.1 | 138.3 | 137.1 | 137.4 | 135.6 | 133.6 | 132.3 | 130.9 | |
| Goodwill | 737.9 | 738.5 | 736.0 | 734.7 | 737.2 | 735.4 | 735.4 | 735.8 | 734.3 | 735.5 | |
| Intangible Assets | 172.0 | 177.3 | 240.1 | 246.7 | 194.0 | 260.3 | 268.7 | 277.8 | 218.9 | 226.7 | |
| Long-Term Investments | 54.3 | 54.0 | 52.5 | 52.7 | 50.6 | 50.3 | 43.9 | 54.8 | 41.6 | 35.0 | |
| Other Long-Term Assets | 122.6 | 123.9 | 76.8 | 75.5 | 131.5 | 72.1 | 73.0 | 64.4 | 144.7 | 151.6 | |
| Total Long-Term Assets | 1,289.0 | 1,300.7 | 1,311.8 | 1,305.5 | 1,292.3 | 1,296.0 | 1,293.8 | 1,299.3 | 1,307.8 | 1,312.5 | |
| Total Assets | 1,948.6 | 2,145.5 | 2,151.5 | 2,121.0 | 2,303.6 | 2,291.7 | 2,283.8 | 2,226.9 | 2,221.6 | 2,193.9 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 49.7 | 51.8 | 45.0 | 63.4 | 71.5 | 40.3 | 46.4 | 38.0 | 48.3 | 27.1 | 22.6 | 19.4 | 16.5 | 18.3 | 11.0 | 13.2 | |
| Short-Term Debt | 10.5 | 185.0 | 10.5 | 10.8 | 488.2 | 12.2 | 10.1 | 9.0 | 15.2 | 8.4 | 8.3 | 4.8 | 5.6 | 4.7 | -0.1 | -0.2 | |
| Other Current Liabilities | 186.1 | 145.5 | 177.8 | 235.3 | 204.3 | 123.9 | 89.7 | 75.7 | 62.9 | 57.9 | 40.0 | 34.3 | 28.4 | 20.8 | 14.5 | 16.4 | |
| Current Liabilities | 407.1 | 595.7 | 367.8 | 428.4 | 876.2 | 276.4 | 237.0 | 204.6 | 212.5 | 180.9 | 124.6 | 112.3 | 93.1 | 85.0 | 58.7 | 58.0 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 62.5 | 62.4 | 53.3 | 51.8 | 47.8 | 49.7 | 43.1 | 45.0 | 49.9 | 47.2 | |
| Short-Term Debt | 0.0 | 186.7 | 186.1 | 185.0 | 582.6 | 10.5 | 10.5 | -39.4 | -40.8 | -48.6 | |
| Other Current Liabilities | 215.3 | 191.7 | 130.2 | 145.5 | 175.9 | 138.0 | 126.6 | 177.8 | 159.1 | 163.5 | |
| Current Liabilities | 456.6 | 594.4 | 607.5 | 595.7 | 961.5 | 407.1 | 416.4 | 367.8 | 369.4 | 370.2 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 571.2 | 197.5 | 603.6 | 606.0 | 39.9 | 516.1 | 100.7 | 135.4 | 194.9 | 245.7 | 0.0 | 0.0 | 0.0 | 0.0 | -11.7 | -9.6 | |
| Capital Leases | 33.7 | 41.8 | 33.9 | 39.4 | 39.9 | 48.9 | 50.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 1.3 | 1.1 | 1.6 | 2.1 | 51.7 | 39.6 | 39.1 | 41.5 | 28.6 | 51.6 | 21.8 | 30.5 | 28.2 | 26.4 | 11.7 | 9.6 | |
| Total Liabilities | 1,088.8 | 877.6 | 1,037.9 | 1,080.6 | 995.8 | 857.0 | 395.6 | 401.6 | 463.1 | 503.5 | 176.4 | 170.1 | 144.2 | 136.1 | 79.1 | 77.8 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 194.9 | 197.8 | 199.7 | 197.5 | 31.5 | 605.0 | 605.0 | 603.6 | 601.7 | 603.6 | |
| Capital Leases | 27.6 | 30.8 | 44.6 | 41.8 | 42.1 | 44.2 | 45.1 | 33.9 | 32.8 | 35.5 | |
| Def. Tax Liability | 1.3 | 1.3 | 1.2 | 1.1 | 1.4 | 1.3 | 1.5 | 1.6 | 1.6 | 1.5 | |
| Total Liabilities | 727.7 | 881.9 | 894.4 | 877.6 | 1,072.3 | 1,088.8 | 1,095.2 | 1,037.9 | 1,034.1 | 1,030.3 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | 358.4 | 382.9 | 370.4 | 390.7 | 368.6 | 290.7 | 258.8 | 197.5 | 122.6 | 100.4 | 99.8 | 69.0 | 38.5 | 14.5 | -1.6 | -12.0 | |
| Comprehensive Income | -14.9 | -17.2 | -13.4 | -17.1 | -8.4 | -5.5 | -9.4 | -10.9 | -6.1 | -9.5 | -2.7 | -1.4 | 0.2 | 0.1 | 0.0 | 0.0 | |
| Total Common Equity | 1,202.8 | 1,243.3 | 1,189.0 | 1,130.1 | 1,146.7 | 967.5 | 845.3 | 679.6 | 517.2 | 431.6 | 402.4 | 390.1 | 348.3 | 307.6 | 282.9 | 265.5 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Retained Earnings | 387.0 | 381.5 | 375.9 | 382.9 | 367.0 | 358.4 | 354.7 | 370.4 | 384.7 | 379.2 | |
| Comprehensive Income | -9.3 | -7.5 | -13.8 | -17.2 | -10.3 | -14.9 | -14.8 | -13.4 | -17.1 | -14.2 | |
| Total Common Equity | 1,220.9 | 1,263.6 | 1,257.1 | 1,243.3 | 1,231.3 | 1,202.8 | 1,188.6 | 1,189.0 | 1,187.4 | 1,163.6 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 615.4 | 382.5 | 614.1 | 616.7 | 528.1 | 516.1 | 100.7 | 135.4 | 210.1 | 254.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 1,202.8 | 1,243.3 | 1,189.0 | 1,130.1 | 1,146.7 | 967.5 | 845.3 | 679.6 | 517.2 | 431.6 | 402.4 | 390.1 | 348.3 | 307.6 | 282.9 | 265.5 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 1,220.9 | 1,263.6 | 1,257.1 | 1,243.3 | 1,231.3 | 1,202.8 | 1,188.6 | 1,189.0 | 1,187.4 | 1,163.6 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -20.8 | 2.1 | 12.5 | -20.4 | 5.6 | 77.8 | 32.2 | 61.3 | 37.7 | 20.6 | 0.6 | 30.8 | 30.5 | 24.0 | 16.2 | 10.4 | 4.9 | |
| Depreciation & Amortization | 165.1 | 86.6 | 89.8 | 95.6 | 99.2 | 84.9 | 71.6 | 64.1 | 51.4 | 51.5 | 58.4 | 25.6 | 20.3 | 18.4 | 13.3 | 8.0 | 8.6 | |
| Stock-Based Compensation | 45.8 | 44.5 | 39.3 | 55.3 | 68.2 | 53.2 | 44.7 | 34.0 | 28.9 | 21.9 | 19.5 | 14.9 | 12.8 | 11.2 | 9.2 | 9.5 | 9.0 | |
| Change Working Capital | 79.1 | -8.3 | 58.3 | 43.7 | -73.5 | -3.3 | 37.3 | -15.8 | -10.7 | -44.4 | -20.4 | -33.8 | -1.4 | -1.0 | -2.3 | 2.4 | -1.6 | |
| Change In Accounts Receivable | 22.3 | 41.4 | -5.0 | 49.2 | -60.4 | -43.2 | 12.0 | -23.5 | -6.2 | -39.1 | 8.0 | -18.3 | -22.8 | -3.6 | -9.3 | 5.9 | -1.3 | |
| Change In Accounts Payable | 3.0 | -9.3 | 7.2 | -17.5 | -7.8 | 29.1 | -6.3 | 7.9 | -9.2 | 19.7 | -5.0 | -2.8 | 1.6 | -1.8 | 1.8 | -2.2 | 2.9 | |
| Change In Inventories | 31.4 | -11.2 | 5.4 | 38.0 | -30.1 | -25.7 | 12.4 | -8.1 | -6.8 | -26.8 | -3.4 | -10.4 | 1.4 | -5.4 | 2.5 | -9.4 | 0.1 | |
| Other Non-cash Items | 34.7 | 3.7 | 2.6 | 18.0 | 15.5 | 22.5 | 6.6 | 2.6 | 2.4 | 2.1 | 0.8 | -2.7 | 1.5 | 2.0 | 0.4 | -3.3 | -2.7 | |
| Cash from Operations | 204.1 | 0.0 | 0.0 | 181.1 | 77.8 | 231.8 | 185.9 | 145.0 | 104.0 | 24.8 | 47.9 | 33.8 | 65.2 | 55.3 | 39.5 | 31.2 | 20.6 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -2.0 | 5.5 | 5.6 | -7.0 | 15.8 | 8.6 | 3.7 | -15.7 | -14.4 | 5.6 | |
| Depreciation & Amortization | 19.8 | 21.4 | 21.6 | 21.8 | 22.2 | 21.6 | 22.8 | 23.2 | 95.6 | 23.6 | |
| Stock-Based Compensation | 0.0 | 11.2 | 10.5 | 10.8 | 0.0 | 11.6 | 10.0 | 8.6 | 12.2 | 15.0 | |
| Change Working Capital | 0.0 | -13.9 | 2.3 | 3.3 | 20.8 | -56.3 | 18.9 | 37.4 | 8.8 | 13.9 | |
| Change In Accounts Receivable | 31.5 | -12.0 | 18.9 | 5.5 | -9.1 | -1.7 | 0.6 | 2.3 | 20.5 | -1.1 | |
| Change In Accounts Payable | -20.0 | 0.0 | 9.8 | 0.9 | 4.3 | -1.8 | 6.2 | -1.4 | -4.2 | 2.4 | |
| Change In Inventories | 6.5 | -1.8 | -13.5 | -2.5 | 5.6 | -5.8 | 4.9 | 6.3 | 6.3 | 13.9 | |
| Other Non-cash Items | 15.1 | 0.8 | 0.9 | 0.8 | 3.0 | 38.7 | 6.5 | 1.0 | -66.9 | 2.2 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 38.4 | 57.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -52.4 | -40.4 | -36.5 | -41.5 | -60.7 | -58.3 | -54.9 | -61.7 | -54.4 | -30.5 | -29.2 | -20.1 | -22.6 | -20.5 | -20.6 | -13.1 | -7.1 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 2.1 | -354.2 | -225.0 | 0.0 | 0.0 | -4.4 | -312.2 | -25.5 | -20.7 | 0.0 | -156.3 | 0.2 | -5.7 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 29.4 | 32.0 | 0.0 | 0.0 | -6.6 | 9.6 | 4.7 | -1.0 | 0.0 | 5.4 | -8.1 | -8.1 | |
| Sales of Investment | -12.1 | -10.2 | -10.4 | -10.4 | -15.4 | 3.3 | -2.9 | -3.7 | -1.7 | 6.6 | -9.6 | -4.7 | 1.0 | 1.7 | 8.1 | 8.1 | 1.4 | |
| Other Investing Activities | -14.2 | 0.0 | 0.0 | -3.1 | 15.4 | -32.7 | -29.1 | 3.7 | 1.7 | 0.0 | 0.0 | 0.0 | 0.0 | -1.7 | -5.3 | -0.2 | -3.6 | |
| Cash from Investing | -52.4 | 0.0 | 0.0 | -55.0 | -58.7 | -412.5 | -279.9 | -61.7 | -54.4 | -35.0 | -341.3 | -45.6 | -43.3 | -20.5 | -168.7 | -13.1 | -23.1 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -14.4 | -9.8 | -15.9 | -11.2 | -13.6 | -1.5 | -13.5 | -12.3 | -12.4 | -14.2 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | -1.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | -1.1 | -11.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.3 | -3.6 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -12.4 | -14.2 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -8.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -200.0 | -90.0 | -77.0 | -102.5 | -34.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 20.3 | 382.5 | -231.5 | -2.6 | 88.7 | 12.0 | 615.4 | 55.3 | 2.3 | 58.5 | 288.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 16.2 | 0.0 | 0.0 | 23.2 | 0.0 | 0.0 | 0.0 | 37.8 | 39.6 | 13.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.8 | 7.0 | |
| Repurchase of Common Stock | -5.2 | -77.6 | 0.0 | -7.4 | -52.2 | 0.0 | -53.0 | 0.0 | 0.0 | 0.0 | 0.0 | -50.0 | -24.1 | -21.0 | -12.4 | -12.6 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 3.7 | 0.0 | 0.0 | 23.4 | 31.3 | 47.4 | 709.3 | 28.7 | 23.8 | 78.7 | 300.2 | 18.2 | 23.9 | 28.3 | 12.1 | 3.9 | 1.9 | |
| Cash from Financing | 11.3 | 0.0 | 0.0 | 23.4 | -21.0 | 47.4 | 456.3 | -23.5 | -13.6 | -9.9 | 265.7 | -31.8 | -0.2 | 7.4 | -0.2 | -1.8 | 8.9 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 194.9 | -189.5 | -1.4 | 3.3 | -231.6 | -1.3 | -0.1 | 1.5 | 12.4 | -1.9 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 7.8 | |
| Repurchase of Common Stock | 0.0 | -61.9 | -15.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.2 | -2.7 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 13.1 | 2.8 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 13.1 | 2.8 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 160.6 | -147.6 | -102.4 | 148.1 | -2.8 | -134.3 | 362.7 | 60.0 | 34.8 | -22.1 | -27.7 | -43.7 | 21.4 | 42.2 | -129.4 | 16.1 | 6.4 | |
| Closing Cash Balance | 578.3 | 251.0 | 398.6 | 501.0 | 352.8 | 355.6 | 489.9 | 127.2 | 67.2 | 32.4 | 54.5 | 82.2 | 125.9 | 104.5 | 62.3 | 191.8 | 175.6 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 25.6 | -206.0 | 17.1 | 15.8 | -194.3 | 14.6 | 28.3 | 49.0 | 38.3 | 45.0 | |
| Closing Cash Balance | 251.0 | 225.5 | 431.5 | 414.4 | 398.6 | 592.9 | 578.3 | 550.0 | 501.0 | 462.7 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 151.6 | 86.9 | 151.3 | 126.1 | 17.0 | 173.5 | 131.0 | 83.3 | 49.6 | -5.7 | 18.8 | 13.7 | 42.6 | 34.8 | 18.9 | 18.1 | 13.5 | |
| Real Free Cash Flow | 105.8 | 42.4 | 111.9 | 70.8 | -51.2 | 120.3 | 86.3 | 49.3 | 20.7 | -27.6 | -0.7 | -1.2 | 29.8 | 23.7 | 9.7 | 8.6 | 4.5 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 20.2 | 18.5 | 31.0 | 14.8 | 47.2 | 9.4 | 45.2 | 37.6 | 26.0 | 42.8 | |
| Real Free Cash Flow | 20.2 | 7.3 | 20.4 | 4.0 | 47.2 | -2.2 | 35.1 | 29.0 | 13.9 | 27.8 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 792.7 | 87.8 | 120.8 |
| P/S | 1.4 | 3 | 9.7 |
| P/B | 1.3 | 3.1 | 738.2 |
| P/FCF | 31.3 | -11.6 | 111.3 |
| Market cap | $1.7 | $1.8 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 13 % | 0 % |
| Debt to Income | 9497.8 % | 769.8 % | 0 % |
| Debt to Free cash flow | 375.3 % | 9.9 % | 0 % |
| Interest expense percentage | 47.3 % | -2.3 % | 18.1 % |
| Current ratio | 1.4 | 2.4 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 0.2 % | 3.7 % | 0 % |
| ROA | 0.1 % | 2.4 % | 0 % |
| CapEx to Revenue | 4.3 % | 5 % | 2.4 % |
| RaD to Revenue | 0 % | 7.8 % | 0 % |
| ROEM | 322,846.0 | 261501.6 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 42.5 % | 48.7 % | 89.7 % |
| Operating margin | 0.4 % | 4.7 % | 37.4 % |
| Net margin | 0.2 % | 3.5 % | 37.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 45.0 mil | 40.3 mil |
| Employee count | 3.7 tis | 1.7 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
